Seguir
Andreas Hougaard Laustsen
Título
Citado por
Citado por
Año
Causes and consequences of snake venom variation
NR Casewell, TNW Jackson, AH Laustsen, K Sunagar
Trends in pharmacological sciences 41 (8), 570-581, 2020
2622020
Basics of antibody phage display technology
L Ledsgaard, M Kilstrup, A Karatt-Vellatt, J McCafferty, AH Laustsen
Toxins 10 (6), 236, 2018
2512018
Pros and cons of different therapeutic antibody formats for recombinant antivenom development
AH Laustsen, JM Gutiérrez, C Knudsen, KH Johansen, ...
Toxicon 146, 151-175, 2018
1702018
Bee updated: current knowledge on bee venom and bee envenoming therapy
MB Pucca, FA Cerni, IS Oliveira, TP Jenkins, L Argemí, CV Sørensen, ...
Frontiers in immunology 10, 2090, 2019
1652019
Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development
AH Laustsen, B Lomonte, B Lohse, J Fernández, JM Gutiérrez
Journal of proteomics 119, 126-142, 2015
1422015
From fangs to pharmacology: the future of snakebite envenoming therapy
A H Laustsen, M Engmark, C Milbo, J Johannesen, B Lomonte, ...
Current Pharmaceutical Design 22 (34), 5270-5293, 2016
1332016
History of envenoming therapy and current perspectives
MB Pucca, FA Cerni, R Janke, E Bermúdez-Méndez, L Ledsgaard, ...
Frontiers in immunology 10, 1598, 2019
1202019
In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies
AH Laustsen, A Karatt-Vellatt, EW Masters, AS Arias, U Pus, C Knudsen, ...
Nature communications 9 (1), 3928, 2018
1162018
Scorpion venom: detriments and benefits
S Ahmadi, JM Knerr, L Argemi, KCF Bordon, MB Pucca, FA Cerni, ...
Biomedicines 8 (5), 118, 2020
1142020
Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca
LP Lauridsen, AH Laustsen, B Lomonte, JM Gutiérrez
Journal of proteomics 150, 98-108, 2017
1032017
Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score
AH Laustsen, B Lohse, B Lomonte, M Engmark, JM Gutiérrez
Toxicon 104, 43-45, 2015
1002015
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
AH Laustsen, KH Johansen, M Engmark, MR Andersen
PLoS neglected tropical diseases 11 (2), e0005361, 2017
972017
Animal immunization, in vitro display technologies, and machine learning for antibody discovery
AH Laustsen, V Greiff, A Karatt-Vellatt, S Muyldermans, TP Jenkins
Trends in Biotechnology 39 (12), 1263-1273, 2021
962021
Innovative immunization strategies for antivenom development
E Bermúdez-Méndez, A Fuglsang-Madsen, S Føns, B Lomonte, ...
Toxins 10 (11), 452, 2018
872018
Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins
AH Laustsen, JM Gutiérrez, B Lohse, AR Rasmussen, J Fernández, ...
Toxicon 99, 23-35, 2015
872015
Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)
LP Lauridsen, AH Laustsen, B Lomonte, JM Gutiérrez
Journal of proteomics 136, 248-261, 2016
862016
Advances in antibody phage display technology
L Ledsgaard, A Ljungars, C Rimbault, CV Sørensen, T Tulika, J Wade, ...
Drug Discovery Today 27 (8), 2151-2169, 2022
852022
Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims
RM Kini, SS Sidhu, AH Laustsen
Toxins 10 (12), 534, 2018
842018
Biotechnological trends in spider and scorpion antivenom development
AH Laustsen, M Solà, EC Jappe, S Oscoz, LP Lauridsen, M Engmark
Toxins 8 (8), 226, 2016
822016
Toxin synergism in snake venoms
AH Laustsen
Toxin Reviews 35 (3-4), 165-170, 2016
692016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20